Browse the evidence

Intermittent Fasting (IF) regimens (5:2, ADF, ADMF, TRF) produce weight loss comparable to daily caloric restriction (CR), but may offer superior insulin-sensitizing benefits independent of weight loss.

If you are choosing between Intermittent Fasting and daily calorie restriction for weight loss, know that both methods are equally effective for losing weight. However, IF may offer extra benefits for your metabolic health, such as better insulin sensitivity, which might be important if you have prediabetes or metabolic syndrome. Choose the method you can sustain long-term.

High body mass index (BMI) is a strong independent risk factor for the development and progression of chronic kidney disease (CKD), primarily driven by compensatory glomerular hyperfiltration and increased intraglomerular pressure.

Maintaining a healthy weight is one of the most effective ways to protect your kidneys. Excess body weight forces your kidneys to work harder (hyperfiltration), which can cause long-term damage. Focus on sustainable lifestyle changes like balanced nutrition and regular physical activity to manage weight, especially if you have a family history of kidney issues or high blood pressure.

Obesity increases the risk of kidney stones (nephrolithiasis) and kidney cancer through mechanisms involving insulin resistance, acidic urine, and adipose-derived inflammatory factors.

If you are overweight, you are at higher risk for kidney stones and kidney cancer. This is partly due to how your body processes acids and minerals. Staying well-hydrated and maintaining a healthy weight through balanced eating can help reduce these risks. Be cautious with extreme weight loss methods, as they can sometimes increase stone risk.

Resistance exercise-induced skeletal muscle hypertrophy is primarily regulated by internal biological variables (e.g., mechanotransduction, mTORC1 signaling, ribosomal biogenesis) rather than external programming alone, with internal variables acting as the dominant determinant of the hypertrophic response.

To maximize muscle growth, focus on consistent resistance training that provides mechanical load. Your body's internal biological machinery (signaling pathways, gene expression) will determine how much muscle you build from that load. Don't chase acute hormone spikes or muscle soreness, as these are not the primary drivers of long-term hypertrophy.

Two weeks of acute physical inactivity (step count <1,000/day) causes a significant decline in glycemic control and integrated muscle protein synthesis in overweight, prediabetic older adults, and these metabolic impairments fail to recover after two weeks of returning to habitual activity levels.

If you are an older adult with prediabetes, even a short period of reduced activity (fewer than 1,000 steps a day) can worsen your blood sugar control and muscle building processes. Crucially, simply going back to your normal activity level for two weeks may not be enough to fix these issues. You may need to be more proactive, such as engaging in specific exercise or medical management, to prevent these declines and help your body recover faster after periods of inactivity.

Six months of caloric restriction combined with aerobic exercise significantly improves autonomic nervous system balance (decreased sympathetic, increased parasympathetic activity) in overweight individuals, whereas caloric restriction alone does not achieve statistical significance.

If you are overweight and want to improve your heart's stress regulation (autonomic balance), combining a moderate calorie reduction with regular aerobic exercise is more effective than dieting alone. Aim for a combined 25% energy deficit, split between what you eat and how much you move, sustained over six months.

Massive weight loss induces significant metabolic adaptation (reduced resting metabolic rate beyond what is predicted by body composition changes) that is strongly correlated with the degree of energy imbalance, rate of weight loss, and changes in circulating leptin levels.

After losing a large amount of weight, your body will biologically resist keeping it off by slowing your metabolism and altering hunger hormones (leptin). This is not a failure of willpower but a strong physiological adaptation. Expecting to maintain massive weight loss requires acknowledging this metabolic defense and likely ongoing, structured energy management.

Performing resistance exercise immediately after endurance exercise enhances Akt phosphorylation (a key anabolic signaling pathway) compared to performing resistance exercise alone, whereas performing endurance exercise after resistance exercise does not augment this response.

If you combine cardio and weights in one session, the order changes your body's molecular signals. Doing resistance training after cardio may actually boost Akt signaling (a growth pathway) more than doing resistance alone. However, this doesn't mean all growth pathways are boosted; other markers like mTOR targets showed different patterns. Don't stress about order for every goal, but be aware that 'interference' is complex and order-dependent.

Performing resistance exercise before endurance exercise exacerbates the transcriptional response of muscle atrophy genes (MuRF) compared to performing endurance exercise before resistance.

If you do resistance training before cardio, your body may upregulate genes associated with muscle breakdown (MuRF) more than if you do cardio first. This suggests that 'weights first' might have a catabolic cost in terms of specific gene expression, even if it boosts growth signals like Akt. Balance your training to manage these competing signals.

Aging causes 'anabolic resistance,' characterized by a blunted muscle protein synthesis response to feeding, which contributes to sarcopenia.

As you age, your body becomes less efficient at turning food into muscle (anabolic resistance). To combat this, you likely need to consume slightly more protein per meal or ensure you are doing resistance exercise to 'wake up' the muscle's synthetic machinery.

Maintenance of weight loss is physiologically distinct from active weight loss, characterized by a 'perfect physiological storm' of increased appetite and decreased energy expenditure that actively opposes weight maintenance.

Accept that maintaining weight loss is biologically harder than losing it. Your body will fight back with increased hunger and lower energy expenditure. To succeed, you must implement strategies that account for this 'storm,' such as higher physical activity levels to offset the metabolic slowdown, rather than relying solely on willpower or extreme restriction.

Leptin repletion to pre-weight-loss levels reverses most physiological adaptations (hypometabolism and hyperphagia) in weight-reduced individuals, proving that low leptin drives these adaptations.

While leptin therapy is not currently a standard commercial treatment for obesity, this research highlights that the biological drive to regain weight is mediated by low leptin levels. This underscores why weight maintenance is so difficult and why future pharmacotherapies targeting these pathways (like GLP-1 agonists which mimic satiety signals) are crucial.

An isocaloric ketogenic diet decreases insulin-mediated antilipolysis (the ability of insulin to suppress fat breakdown) compared to a baseline diet, regardless of the meal consumed.

On a ketogenic diet, your body's fat cells become less responsive to insulin's signal to stop breaking down fat. This means insulin is less effective at suppressing fat release, even if your blood sugar control remains stable. This is a key metabolic shift to understand when managing body composition on keto.

AOM therapy requires monitoring and potential dose reduction of concomitant medications for diabetes and hypertension due to rapid weight loss and improved metabolic parameters.

If you take medication for diabetes or high blood pressure, tell your doctor you are starting an AOM. Your doses may need to be lowered quickly as you lose weight to prevent dangerous drops in blood sugar or blood pressure.

Higher resistance training volume (3 sets vs 1 set) yields greater muscle hypertrophy and strength gains, but this benefit is contingent upon the individual's capacity for ribosome biogenesis (total RNA accumulation).

If you are new to resistance training, doing 3 sets per exercise will likely yield better muscle and strength gains than doing just 1 set. However, your body's ability to produce ribosomes (total RNA) determines how much benefit you get from those extra sets. If you are short on time, 1 set is still effective, but 3 sets is superior for maximizing growth.

Metformin is the primary first-line oral treatment for type 2 diabetes across all age groups due to its efficacy, versatility, and cost-effectiveness, with benefits extending to cardiovascular and potential anti-neoplastic properties.

Start with metformin as your primary medication. It is the standard, effective, and affordable choice for managing blood sugar. While it may cause mild stomach issues initially, it is generally well-tolerated and helps protect your heart and kidneys over the long term.

Resistance exercise performed at low intensity (30% 1RM) to volitional fatigue stimulates myofibrillar protein synthesis rates equally to high intensity (90% 1RM) exercise, challenging the necessity of heavy loads for muscle growth.

You do not need to lift heavy weights to build muscle. If you lift a lighter weight (30% of your max) until you physically cannot complete another repetition, your muscles will grow just as effectively as they would with heavy weights. Focus on reaching failure, not just moving heavy loads.

Higher circulating levels of plasma very-long-chain saturated fatty acids (VLCSFAs: C20:0, C22:0, C24:0) are associated with a significantly lower risk of incident coronary heart disease (CHD) in US men and women.

This observational study suggests that higher levels of specific very-long-chain saturated fatty acids (C20:0, C22:0, C24:0) in the blood are linked to a lower risk of heart disease. However, this does not mean you should intentionally consume more of these fats, as their source and overall dietary context are critical. The findings highlight the complexity of lipid metabolism and suggest that blood markers of these fatty acids may serve as useful indicators of cardiovascular health rather than direct targets for supplementation.

Circulating very-long-chain saturated fatty acids (VLCSFAs) in plasma are associated with favorable cardiovascular risk markers, including higher HDL-C, lower triglycerides, and higher adiponectin.

Higher levels of specific saturated fatty acids in the blood are linked to better cholesterol profiles (higher HDL, lower triglycerides) and lower inflammation. This suggests these fatty acids may play a role in metabolic health, distinct from other types of saturated fats.

Newer FDA-approved pharmacological interventions (Lorcaserin, Phentermine-Topiramate ER) produce greater weight loss than older medications but remain less effective than bariatric surgery and carry risks of central nervous system and cardiovascular adverse effects.

Newer weight loss drugs like Lorcaserin and Qsymia work better than older options but still produce less weight loss than surgery. They carry risks of side effects like nausea or mood changes, so they require medical supervision. They are an option if surgery is not desired or possible.

Lorcaserin, a selective serotonin 2C receptor agonist, produces modest but clinically significant weight loss (mean 3.2-5.0 kg) compared to placebo, though tolerance may develop over two years of treatment.

Lorcaserin offers a modest weight loss benefit (approx. 3-5 kg) over lifestyle changes alone for obese patients. It works by targeting serotonin receptors to reduce appetite. However, tolerance can develop, leading to weight regain in the second year. It is only prescribed if you lose at least 5% of your body weight in the first 12 weeks; otherwise, it is stopped.

GLP-1 receptor agonists improve cardiovascular risk factors (blood pressure, lipid profiles, endothelial function) and reduce cardiovascular events in patients with type 2 diabetes and obesity.

GLP-1 injections not only help with weight and blood sugar but also improve heart health by lowering blood pressure, improving cholesterol, and reducing inflammation. They are recommended for patients with T2DM and obesity to reduce cardiovascular risk.

Resistance exercise decreases the phosphorylation of eIF2Bε, a mechanism that potentiates the feeding-induced stimulation of p70S6K1 and rpS6, thereby enhancing muscle protein synthesis signaling in young men.

To maximize muscle growth, you must combine resistance training with adequate nutrition. This study shows that exercise changes how your muscles respond to food by deactivating inhibitory signals (eIF2Bε phosphorylation). Without the exercise stimulus, feeding alone does not trigger the same level of anabolic signaling (p70S6K1 and rpS6) as the combination of both.

Statins are safe and effective as first-line treatment for hyperlipidemia in MASLD patients, despite under-prescription, and may reduce cardiovascular events and liver disease burden.

If you have MASLD and high cholesterol or CVD risk, ask your doctor about statins. They are safe for your liver, even if you have some liver scarring, and are the first-line treatment to lower your risk of heart disease. Do not avoid them due to fear of liver damage.